186 related articles for article (PubMed ID: 22573848)
21. Continuous antiretroviral therapy decreases bone mineral density.
Grund B; Peng G; Gibert CL; Hoy JF; Isaksson RL; Shlay JC; Martinez E; Reiss P; Visnegarwala F; Carr AD;
AIDS; 2009 Jul; 23(12):1519-29. PubMed ID: 19531929
[TBL] [Abstract][Full Text] [Related]
22. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
[TBL] [Abstract][Full Text] [Related]
23. Risk factors of osteopenia in HIV-infected women: no role of antiretroviral therapy.
Libois A; Clumeck N; Kabeya K; Gerard M; De Wit S; Poll B; Tondeur M; Rozenberg S
Maturitas; 2010 Jan; 65(1):51-4. PubMed ID: 19939594
[TBL] [Abstract][Full Text] [Related]
24. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.
Duvivier C; Kolta S; Assoumou L; Ghosn J; Rozenberg S; Murphy RL; Katlama C; Costagliola D;
AIDS; 2009 Apr; 23(7):817-24. PubMed ID: 19363330
[TBL] [Abstract][Full Text] [Related]
25. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
[TBL] [Abstract][Full Text] [Related]
26. Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors.
Tsekes G; Chrysos G; Douskas G; Paraskeva D; Mangafas N; Giannakopoulos D; Papanikolaou M; Georgiou E; Lazanas MC
HIV Med; 2002 Apr; 3(2):85-90. PubMed ID: 12010354
[TBL] [Abstract][Full Text] [Related]
27. Analysis of bone mineral content in horizontally HIV-infected children naïve to antiretroviral treatment.
Mora S; Zamproni I; Giacomet V; Cafarelli L; Figini C; Viganò A
Calcif Tissue Int; 2005 May; 76(5):336-40. PubMed ID: 16075365
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral therapy and bone mineral measurements in HIV-infected youths.
Zuccotti G; Viganò A; Gabiano C; Giacomet V; Mignone F; Stucchi S; Manfredini V; Marinacci F; Mora S
Bone; 2010 Jun; 46(6):1633-8. PubMed ID: 20211284
[TBL] [Abstract][Full Text] [Related]
29. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
Maia BS; Engelson ES; Wang J; Kotler DP
Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.
Zeng YQ; Xiao J; Li CL; Wang Y; Zhang L; Pang XL; Wang D; Du J; Zhao HX
Chin Med J (Engl); 2020 Dec; 133(24):2940-2946. PubMed ID: 33278100
[TBL] [Abstract][Full Text] [Related]
31. Efavirenz is associated with higher bone mass in South African children with HIV.
Arpadi SM; Shiau S; Strehlau R; Patel F; Mbete N; McMahon DJ; Kaufman JJ; Coovadia A; Kuhn L; Yin MT
AIDS; 2016 Oct; 30(16):2459-2467. PubMed ID: 27427876
[TBL] [Abstract][Full Text] [Related]
32. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals.
Brown TT; Chen Y; Currier JS; Ribaudo HJ; Rothenberg J; Dubé MP; Murphy R; Stein JH; McComsey GA
J Acquir Immune Defic Syndr; 2013 Jul; 63(3):323-30. PubMed ID: 23591634
[TBL] [Abstract][Full Text] [Related]
33. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
34. Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.
Nolan D; Upton R; McKinnon E; John M; James I; Adler B; Roff G; Vasikaran S; Mallal S
AIDS; 2001 Jul; 15(10):1275-80. PubMed ID: 11426072
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
[TBL] [Abstract][Full Text] [Related]
36. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
Atencio P; Cabello A; Conesa-Buendía FM; Pérez-Tanoira R; Prieto-Pérez L; Carrillo I; Álvarez B; Arboiro-Pinel R; Díaz-Curiel M; Herrero-Beaumont G; Mediero A; Górgolas M
BMC Infect Dis; 2021 Jun; 21(1):542. PubMed ID: 34107907
[TBL] [Abstract][Full Text] [Related]
37. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
Natukunda E; Szubert A; Otike C; Namyalo I; Nambi E; Bamford A; Doerholt K; Gibb DM; Musiime V; Musoke P
PLoS One; 2023; 18(7):e0288877. PubMed ID: 37471330
[TBL] [Abstract][Full Text] [Related]
38. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
[TBL] [Abstract][Full Text] [Related]
39. Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy.
Shlay JC; Bartsch G; Peng G; Wang J; Grunfeld C; Gibert CL; Visnegarwala F; Raghavan SS; Xiang Y; Farrough M; Perry HE; Kotler D; El-Sadr WM
J Acquir Immune Defic Syndr; 2007 Apr; 44(5):506-17. PubMed ID: 17325603
[TBL] [Abstract][Full Text] [Related]
40. Low bone mineral density in HIV-positive young Italians and migrants.
Cascio A; Colomba C; Di Carlo P; Serra N; Lo Re G; Gambino A; Lo Casto A; Guglielmi G; Veronese N; Lagalla R; Sergi C
PLoS One; 2020; 15(9):e0237984. PubMed ID: 32881882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
